1 study found for:    19047285 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: erlotinib hydrochloride;   Drug: paclitaxel

Indicates status has not been verified in more than two years